|
|
||||||||

,
,
* Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Departments of
Medicine and
Pathology, Harvard Medical School, Boston, Massachusetts; and
Department of Haematology, Imperial College of Science, Technology and Medicine, London, United Kingdom
Correspondence: Christopher E. Rudd, Imperial College of Science, Technology and Medicine, Department of Haematolgy, Division of Investigative Science, Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 ONN, UK. E-mail: c.rudd{at}ic.ac.uk
CD28 and cytotoxic T-lymphocyte antigen (CTLA)-4 are key coreceptors on the surface of T cells that have opposing effects on T cell activation. Although CD28 enhances proliferation, CTLA-4 markedly inhibits the activation process. These opposing roles are particularly surprising given the structural similarity of the cytoplasmic residues of the two receptors. These include the related CD28SDYMNM and CTLA-4GVYVKM motifs. In this study, we have directly addressed whether these related motifs may play different roles in the activation process by swapping the CTLA-4GVYVKM motif with the CD28SDYMNM motif. Remarkably, stable transfectants of the T cell hybridoma DC27.10 showed that substitution of CTLA-4GVYVKM was sufficient to convert CTLA-4 from a negative signaling coreceptor to a positive CD28-like coreceptor. CD28SDYMNM is therefore sufficient to convey positive signals within CTLA-4. These results demonstrate that CD28SDYMNM and CTLA-4GVYVKM motifs contain sufficient information to distinguish positive versus negative coreceptor signaling in T cells.
Key Words: coreceptor phosphatidylinositol 3-kinase
This article has been cited by other articles:
![]() |
K. M. Dennehy, F. Elias, S.-Y. Na, K.-D. Fischer, T. Hunig, and F. Luhder Mitogenic CD28 Signals Require the Exchange Factor Vav1 to Enhance TCR Signaling at the SLP-76-Vav-Itk Signalosome J. Immunol., February 1, 2007; 178(3): 1363 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Madrenas, L. A. Chau, W. A. Teft, P. W. Wu, J. Jussif, M. Kasaian, B. M. Carreno, and V. Ling Conversion of CTLA-4 from Inhibitor to Activator of T Cells with a Bispecific Tandem Single-Chain Fv Ligand J. Immunol., May 15, 2004; 172(10): 5948 - 5956. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |